Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies. [electronic resource]
- Inflammation Apr 2020
- 393-400 p. digital
Publication Type: Journal Article; Review
1573-2576
10.1007/s10753-019-01157-0 doi
Anti-Asthmatic Agents--administration & dosage Antibodies, Monoclonal, Humanized--administration & dosage Asthma--drug therapy Daclizumab--administration & dosage Drug Delivery Systems--methods Humans Severity of Illness Index T-Lymphocytes, Regulatory--immunology